2m 2m 2m 2m 2m 2m 2m
Nymox Pharma (NYMXF)
OTC
$0.12$0.00 (0.00%)
Price as of Jul 09, 2026- $18.1MMarket Cap
- 25.65%1-Year Change
- BiotechnologyIndustry
Nymox Pharma (NYMXF)
$0.12$0.00 (0.00%)
NYMXF | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.12 | ||
Change | $0.00 (0.00%) | ||
Open | $0.12 | ||
High | $0.12 | ||
Low | $0.12 | ||
Previous Close | $0.12 | ||
Volume | 2,501 | ||
30-Day Average Volume | 38,988 | ||
1-Week Change | 0.00% | ||
1-Month Change | 44.97% | ||
1-Year Change | 25.65% | ||
3-Year Change | -14.29% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 90.5M | ||
Total Assets | $1.6M | ||
Market Cap | $18.1M | ||
Enterprise Value | $16.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | N/A | ||
EBIT | N/A | ||
EBITDA | N/A | ||
Net Working Capital | N/A | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||